- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 14/495 - Transforming growth factor (TGF)
Patent holdings for IPC class C07K 14/495
Total number of patents in this class: 553
10-year publication summary
|
29
|
43
|
33
|
41
|
59
|
48
|
63
|
69
|
57
|
10
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Acceleron Pharma Inc. | 365 |
26 |
| The Johns Hopkins University | 5377 |
14 |
| NGM Biopharmaceuticals, Inc. | 181 |
14 |
| Cue Biopharma, Inc. | 151 |
13 |
| The Regents of the University of California | 18943 |
12 |
| Biocon Limited | 228 |
12 |
| Merck Patent GmbH | 5909 |
11 |
| Amgen Inc. | 3779 |
11 |
| Scholar Rock, Inc. | 93 |
10 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
10 |
| Modernatx, Inc. | 1181 |
8 |
| National Research Council of Canada | 1545 |
8 |
| In3bio Ltd. | 24 |
7 |
| Genzyme Corporation | 1205 |
6 |
| Immatics Biotechnologies GmbH | 1144 |
6 |
| Notogen, Inc. | 6 |
6 |
| Mayo Foundation for Medical Education and Research | 2981 |
5 |
| University Health Network | 979 |
5 |
| President and Fellows of Harvard College | 5792 |
4 |
| Celgene Corporation | 1412 |
4 |
| Other owners | 361 |